With industries now at the acute stage of the European supply chain crisis, ACG, the world’s largest integrated pharmaceutical and nutraceutical manufacturing solutions provider, is committed to working collaboratively with pharmaceutical manufacturers, leveraging its own resilient supply chain and ability to adapt to quickly changing conditions.
At CPhI (1-3 November, Frankfurt), ACG will have representatives from its Capsules and Films & Foils divisions available to demonstrate how they are keeping supply chains moving by helping firms move from crisis to resolution.
The team at ACG is on a mission to help keep the sector moving. With factories, warehouses and distribution capabilities across the globe, the company doesn’t feel the same pressures as other more exclusively Europe-based organisations. This allows ACG to provide far greater supply chain security. In many instances it offers significantly shorter lead times than its competitors. This is the reason ACG has always invested heavily in its supply chain resilience.
Nikunj Desai, Head of Supply Chain at ACG, said: “Because we import from more than 15 countries and export to a further 70+ we’ve invested heavily in systems that give us supply chain resilience. In today’s climate, it has become critical to work closely with customers to help them solve the myriad issues they are currently facing; finding resolutions to problems they may encounter and keeping pharmaceutical supply chains moving.”
Desai continued: “We’re proud of our track record - during the Covid-19 crisis we didn’t miss a single delivery anywhere in the world, with 94% of these deliveries arriving either on time, or sooner than promised.”
With products ranging from capsules, to films & foils, to engineering equipment and inspection systems (all meeting international regulatory requirements), ACG is strategically positioned to offer a range of holistic quality solutions.
Find out more by visiting ACG at CPhI, hall 8, booth 80C12.
